---
figid: PMC6487485__nihms-1504061-f0001
figtitle: Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s
  Disease – An Emerging Role for Gut Microbiome
organisms:
- NA
pmcid: PMC6487485
filename: nihms-1504061-f0001.jpg
figlink: /pmc/articles/PMC149053/figure/fig7/
number: F1
caption: 'Regulation of bile acid synthesis by feedback mechanism and bile acid transport
  through enterohepatic circulation. In the liver the bile acids (CDCA, DCA, LCA,
  CA) activate FXR that inhibits (via a repressor SHP, not shown here) the rate-limiting
  enzyme CYP7A1. The bile acids via FXR/SHP also inhibit the influx transporter NTCP;
  induce BSEP and canalicular bile acid secretion. In the intestine, bile acids, via
  FXR, inhibit the uptake transporter ASBT, decreasing absorption and increasing basolateral
  secretion into portal circulation by inducing OSTα & β. Bile acid activated FXR
  in the intestine also exerts inhibition on CYP7A1 in the liver via FGF19 pathway.
  At the basolateral membrane of hepatocytes, transporters OSTα & β, and also MRP3
  and MRP4, secrete bile acids into the systemic circulation.Abbreviations: ASBT:
  Apical Sodium-dependent Bile acid Transporters; BSEP: Bile Salt Export Pump; FXR:
  Farnesoid X Receptor; NTCP: Sodium/Taurocholate Co-transporting Polypeptide; SHP:
  Small heterodimer partner.'
papertitle: Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s
  Disease – An Emerging Role for Gut Microbiome.
reftext: Siamak MahmoudianDehkordi, et al. Alzheimers Dement. 2019 Jan;15(1):76-92.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9062436
figid_alias: PMC6487485__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6487485__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6487485__nihms-1504061-f0001.html
  '@type': Dataset
  description: 'Regulation of bile acid synthesis by feedback mechanism and bile acid
    transport through enterohepatic circulation. In the liver the bile acids (CDCA,
    DCA, LCA, CA) activate FXR that inhibits (via a repressor SHP, not shown here)
    the rate-limiting enzyme CYP7A1. The bile acids via FXR/SHP also inhibit the influx
    transporter NTCP; induce BSEP and canalicular bile acid secretion. In the intestine,
    bile acids, via FXR, inhibit the uptake transporter ASBT, decreasing absorption
    and increasing basolateral secretion into portal circulation by inducing OSTα
    & β. Bile acid activated FXR in the intestine also exerts inhibition on CYP7A1
    in the liver via FGF19 pathway. At the basolateral membrane of hepatocytes, transporters
    OSTα & β, and also MRP3 and MRP4, secrete bile acids into the systemic circulation.Abbreviations:
    ASBT: Apical Sodium-dependent Bile acid Transporters; BSEP: Bile Salt Export Pump;
    FXR: Farnesoid X Receptor; NTCP: Sodium/Taurocholate Co-transporting Polypeptide;
    SHP: Small heterodimer partner.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - cp
  - ca
  - Coa
  - tRNA:Ala-TGC-1-1
  - tRNA:Ala-TGC-2-1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - smp-30
  - ad
  - cn
  - ti
  - NR4A3
  - CP
  - HSD3B7
  - CYP27A1
  - CYP8B1
  - GCA
  - HLA-DQA2
  - CLTA
  - GUCY2D
  - PTPRC
  - GNAT3
  - CYP7B1
  - bile acid
  - Cholesterol
  - Bile Acids
  - hydroxycholesterol
  - hydroxyl-4-cholesten-3-one
  - 7a-dihydroxy-5-cholestenoic acid
  - CDCA
  - Bile acid
  - CoA
  - amino acid
  - 'N'
  - TCA
  - GCDCA TCDCA
  - DCA
  - UDCA
  - bile acids
  - TUDCA
  - GUDCA TLCA
  - TDCA
  - ti GDCA
  - AD
  - Cytotoxic
---
